Fulgent Genetics Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 80c
November 9, 2021 4:28 PM ESTFulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $4.05, $0.80 better than the analyst estimate of $3.25. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $264 million.
GUIDANCE:
Fulgent Genetics, Inc. sees FY2021 revenue of $930 million, versus the... More
